-
ACLA Statement on Clinical Use of Non-invasive Prenatal Screenings (NIPS)
Washington, D.C. – In response to recent interest in non-invasive prenatal screenings (NIPS) and their use by patients and health care providers, ACLA has issued the ... Read More -
ACLA Statement on Reintroduction of the VALID Act
Washington, D.C. – Following the reintroduction of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, ACLA President Julie Khani issued the following statement: ... Read More -
ACLA Comments on MCIT/Reasonable and Necessary Definition Proposed Rule
-
ACLA Comments on Medicare Coverage of Innovative Technology (MCIT)
-
ACLA Comments on VALID Act